Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells-Reference-Cited by-同舟云学术

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells

Published:2008-06-19 Issue:10 Volume:22 Page:1131-1135
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Archin Nancy M,Eron Joseph J,Palmer Sarah,Hartmann-Duff Anne,Martinson Jeffery A,Wiegand Ann,Bandarenko Nicholas,Schmitz John L,Bosch Ronald J,Landay Alan L,Coffin John M,Margolis David M

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference30 articles.

1. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy;Gulick;N Engl J Med,1997

2. International AIDS Society-USA Panel. Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel;Hammer;JAMA,2006

3. Antiretroviral Therapy (ART) Cohort Collaboration. HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis;May;Lancet,2006

4. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy;Dornadula;JAMA,1999

5. In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months;Di Mascio;J Virol,2003

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells;Antiviral Research;2024-08

2. CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T-cells;2024-07-06

3. HIV Reservoirs and Treatment Strategies toward Curing HIV Infection;International Journal of Molecular Sciences;2024-02-23

4. The Effects of Human Immunodeficiency Virus Type 1 (HIV-1) Antigen-Expanded Specific T-Cell Therapy and Vorinostat on Persistent HIV-1 Infection in People With HIV on Antiretroviral Therapy;The Journal of Infectious Diseases;2024-02-13

5. Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir;Nature Communications;2023-12-18